Stay updated on Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The record history now includes a new Revision: v3.6.6 entry, and the previous Revision: v3.6.5 entry was removed from the list.
    Difference
    0.1%
    Check dated 2026-08-29T18:18:10.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Newest history entry shows Revision: v3.6.5 in the version list. This change is a small metadata update to the study record.
    Difference
    0.1%
    Check dated 2026-08-15T10:56:14.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    New revision entry added: v3.6.4 replaces v3.6.3 in the history. This reflects an update to the record's version history without changing content or study details.
    Difference
    0.1%
    Check dated 2026-07-25T05:15:57.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    The revision history now lists the latest revision as v3.6.3, replacing the previous v3.6.2. This reflects an update to the version trail in the study record history.
    Difference
    0.1%
    Check dated 2026-07-03T20:48:43.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    The record history shows a new revision entry, updating from v3.6.0 to v3.6.2 to reflect a software version change on the page.
    Difference
    0.1%
    Check dated 2026-06-27T00:31:20.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Recruitment status is updated to indicate that no more participants are being sought. A new revision (v3.6.0) has been added, while the earlier revision (v3.5.5) has been removed.
    Difference
    0.2%
    Check dated 2026-06-12T16:36:53.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial page.